Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles

Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles Discovery of orally available spirodiketopiperazine-based CCR5 antagonists Spirodiketopiperazine-based CCR5 antagonist: Discovery of an antiretroviral drug candidate Discovery of 4-[4-({(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid hydrochloride: A highly potent orally available CCR5 selective antagonist Design and synthesis of novel CCR3 antagonists Synthesis and in–vitro anti–HIV–1 evaluation of novel pyrazolo[4,3–c]pyridin–4–one derivatives Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase Synthesis and anti HIV-1 activity of new thiadiazepindioxides Synthesis and anti-HIV activity of pyrrolo-[1,2-d]-(1,4)-benzodiazepin-6-ones Comparative Docking Study of Anibamine as the First Natural Product CCR5 Antagonist in CCR5 Homology Models